In this video, the doctor shares his approach regarding SGL2 Inhibitors in present-day CV mortality reduction in T2DM.
My Approach Towards CV Mortality Reduction In T2DM
Ratan Jha
CONSULTANT NEPHROLOGIST
Join the community and view the full post,
write comments and share this post.
🩺 India's Largest Platform for Doctors
✅ 5,10,000+ Verified Doctors
💬 60,000+ Clinical Discussions
More related to above
India Adds Nearly 10,000 MBBS Seats for 2026 to 2027 Academic Session
Allergy & Immunology
1m ago
65
Andhra Pradesh Reports 12 COVID-19 Infections and Four Deaths Between June 26 and July 16
Anesthesiology
5h ago
151
1
What is the Cause of Excess Ceramide in this Patient?
Nephrology
7h ago
175
1
Mumbai Reports Nearly Threefold Rise in H1N1 Cases During First Half of 2026
Anesthesiology
22h ago
564
3
Climate Change Linked to Measurable Sleep Loss in India
Allergy & Immunology
1d ago
565
4
Communication Skills for Doctors
Allergy & Immunology
1d ago
117
3